| Dr Victor Young Yu, MD | |
|
1500 Cornerside Blvd Ste 300, Vienna, VA 22182-2438 | |
| (847) 593-8460 | |
| Not Available |
| Full Name | Dr Victor Young Yu |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 14 Years |
| Location | 1500 Cornerside Blvd Ste 300, Vienna, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104144906 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usa Vein Clinics Of Chantilly Llc | 6406284462 | 3 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
| Entity Name | Medstar Medical Group Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326450156 PECOS PAC ID: 1557589157 Enrollment ID: O20140826000263 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
| Entity Name | Usa Vein Clinics Of District Of Columbia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710359211 PECOS PAC ID: 2860794401 Enrollment ID: O20160919002665 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
| Entity Name | Usa Vein Clinics Of Chantilly Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124670930 PECOS PAC ID: 6406284462 Enrollment ID: O20200325001981 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
| Entity Name | Usa Vascular Center Of Chantilly Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255901450 PECOS PAC ID: 6002207503 Enrollment ID: O20211216001637 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
| Entity Name | Usa Vascular Centers Of District Of Columbia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841802857 PECOS PAC ID: 0941677413 Enrollment ID: O20221114001102 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
| Entity Name | Usa Vein Clinics Of Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972201879 PECOS PAC ID: 9335513365 Enrollment ID: O20230804000000 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor Young Yu, MD Po Box 971, Northbrook, IL 60065-0971 Ph: (847) 593-8460 | Dr Victor Young Yu, MD 1500 Cornerside Blvd Ste 300, Vienna, VA 22182-2438 Ph: (847) 593-8460 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.
Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The Centers for Disease Control and Prevention (CDC) has released a report titled, "Multistate Outbreak of E. coli O157:H7 Infections Linked to Romaine Lettuce", stating that it is safe to consume romaine lettuce which was implicated in transmitting a toxic strain of E. coli since March this year.
› Verified 7 days ago
Annapurna Chavali Rao, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9900 Vale Rd, Vienna, VA 22181 Phone: 219-614-4893 Fax: 703-255-4984 | |
Dr. Tiberiu Koos, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 8215 Westwood Mews Ct, Vienna, VA 22182 Phone: 703-847-2552 Fax: 763-647-2552 | |
Mehdi Taghipour, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1500 Cornerside Blvd Ste 300, Vienna, VA 22182 Phone: 571-771-3489 | |
Dr. Christopher Michael Curcio, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2186 Harthy Drive, Vienna, VA 22027 Phone: 703-876-5618 | |
Dr. Stephen W. Chang, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1980 Gallows Rd, Vienna, VA 22182 Phone: 703-356-9899 |